The mission of CBR Pharma Insights is to empower companies within the pharmaceutical industry to make the best business decisions possible through providing them with quality, innovative, strategic market research solutions.CBRâs market research solutions are focused on being both proactive reactive in identifying, evaluating, and assessing the key strategic R&D and commercial issues within the pharmaceutical industry.
PI3K Signaling Pathway Analysis: A Shifting Marketed and Pipeline Product Landscape, as Blockbusters Expire and Development Moves Towards Downstream Targets
By CBR Pharma Insights | Pharmaceuticals and Healthcare | Jun 2018 | Page 265
PI3K Signaling Pathway Analysis: A Shifting Marketed and Pipeline Product Landscape, as Blockbusters Expire and Development Moves Towards Downstream Targets PI3K Signaling Pathway Analysis: A Shifting Marketed and Pipeline Product Landscape,....
The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players
By CBR Pharma Insights | Pharmaceuticals and Healthcare | May 2018 | Page 140
The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players GBI Research’s latest report, The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations....
Artificial Intelligence Technologies: Market Prospects - Featuring Expert Panel Views from Industry Survey 2018
By CBR Pharma Insights | Pharmaceuticals and Healthcare | Mar 2018 | Page 104
Artificial Intelligence Technologies: Market Prospects - Featuring Expert Panel Views from Industry Survey 2018 GBI Research’s latest report: “Artificial Intelligence Technologies: Market Prospects - Featuring Expert Panel....
Cosmeceuticals: Global Trends in Market Entry Strategies, Regulatory Framework, Next-Generation Products and Technologies
By CBR Pharma Insights | Pharmaceuticals and Healthcare | Feb 2018 | Page 106
Cosmeceuticals: Global Trends in Market Entry Strategies, Regulatory Framework, Next-Generation Products and Technologies....
Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products such as Glybera and Strimvelis
By CBR Pharma Insights | Pharmaceuticals and Healthcare | Jan 2018 | Page 79
Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products such as Glybera and Strimvelis GBI Researchs latest report: Gene Therapies:....